Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vicam is a global leader in the development of rapid diagnostic solutions for food safety, specifically focusing on mycotoxin detection. As a subsidiary of Waters Corporation, the company provides a comprehensive range of immunoaffinity columns, lateral flow strips, and fluorometric systems. Their technology is designed to identify and quantify harmful contaminants such as aflatoxins, ochratoxins, and fumonisins in agricultural commodities. These tools are essential for food processors, grain handlers, and regulatory agencies to ensure compliance with global health standards. Vicam's products are recognized for their sensitivity, accuracy, and ease of use in both laboratory and field settings. By monitoring the safety of the global food supply, Vicam plays a critical role in protecting public health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vicam.